These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 8572877)

  • 41. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep.
    Marks KA; Mallard CE; Roberts I; Williams CE; Gluckman PD; Edwards AD
    Pediatr Res; 1996 Aug; 40(2):185-91. PubMed ID: 8827765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
    Simon L; Ghaleh B; Puybasset L; Giudicelli JF; Berdeaux A
    J Pharmacol Exp Ther; 1995 Nov; 275(2):659-66. PubMed ID: 7473152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An inhibitor of nitric oxide synthase, N omega-nitro-L-arginine-methyl ester, attenuates hypotension but does not improve cardiac depression in anaphylaxis in dogs.
    Mitsuhata H; Takeuchi H; Saitoh J; Hasome N; Horiguchi Y; Shimizu R
    Shock; 1995 Jun; 3(6):447-53; discussion 454. PubMed ID: 7656070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs.
    Yamada T; Yukioka H; Hayashi M; Asada A; Inoue M
    Acta Anaesthesiol Scand; 1998 Mar; 42(3):358-68. PubMed ID: 9542566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of NG-nitro-L-arginine administration on the hemodynamics and plasma hormone levels during endotoxin shock in dogs].
    Takekoshi K; Kasai K; Nakamura T
    Nihon Naibunpi Gakkai Zasshi; 1993 Mar; 69(3):135-48. PubMed ID: 8385633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of nitric oxide synthase inhibition on the hemodynamic changes in hyperdynamic endotoxemia.
    Wolfárd A; Kaszaki J; Szabó C; Balogh Z; Nagy S
    Acta Chir Hung; 1997; 36(1-4):393-4. PubMed ID: 9408415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitric oxide synthase inhibition and acute renal ischemia: effect on systemic hemodynamics and mortality.
    Atanasova I; Burke TJ; McMurtry IF; Schrier RW
    Ren Fail; 1995 Jul; 17(4):389-403. PubMed ID: 7569111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased aortic blood pressure contributes to potentiated dobutamine inotropic responses after systemic NO synthase inhibition in sheep.
    Penny DJ; Chen H; Smolich JJ
    Cardiovasc Res; 1998 Nov; 40(2):282-9. PubMed ID: 9893721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs.
    Klabunde RE; Ritger RC; Helgren MC
    Eur J Pharmacol; 1991 Jun; 199(1):51-9. PubMed ID: 1893927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia.
    Cheng X; Leung SW; Lo LS; Pang CC
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):372-9. PubMed ID: 12690429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of nitric oxide in gastroduodenal alkaline secretion.
    Bilski J; Konturek SJ
    J Physiol Pharmacol; 1994 Dec; 45(4):541-53. PubMed ID: 7727796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin.
    el Karib AO; Sheng J; Betz AL; Malvin RL
    Clin Exp Hypertens; 1993 Sep; 15(5):819-32. PubMed ID: 7691341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nitric oxide synthase inhibition on myocardial contractility in anesthetized normal and endotoxemic dogs.
    Kaszaki J; Wolfard A; Bari F; Boros M; Parratt JR; Nagy S
    Shock; 1996 Oct; 6(4):279-85. PubMed ID: 8902946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary effects of exogenous and endogenous bradykinin in conscious dogs.
    Puybasset L; Giudicelli JF; Berdeaux A
    Fundam Clin Pharmacol; 1997; 11(4):322-30. PubMed ID: 9263762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs.
    Baumann JE; Persson PB; Ehmke H; Nafz B; Kirchheim HR
    Am J Physiol; 1992 Aug; 263(2 Pt 2):F208-13. PubMed ID: 1510118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs.
    Shen W; Lundborg M; Wang J; Stewart JM; Xu X; Ochoa M; Hintze TH
    J Appl Physiol (1985); 1994 Jul; 77(1):165-72. PubMed ID: 7525527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise.
    Shen W; Xu X; Ochoa M; Zhao G; Bernstein RD; Forfia P; Hintze TH
    Acta Physiol Scand; 2000 Apr; 168(4):675-86. PubMed ID: 10759604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N omega-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs.
    Nishiwaki K; Nyhan DP; Rock P; Desai PM; Peterson WP; Pribble CG; Murray PA
    Am J Physiol; 1992 May; 262(5 Pt 2):H1331-7. PubMed ID: 1590434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogs.
    Chelly JE; Doursout MF; Lechevalier T; Liang YY; Chelly F; Hartley C; Kilbourn RG
    Anesthesiology; 1996 Jul; 85(1):142-9. PubMed ID: 8694360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of NG-methyl-L-arginine in chronically instrumented conscious dogs.
    Lechevalier T; Doursout MF; Chelly JE; Kilbourn RG
    J Appl Physiol (1985); 1994 Jul; 77(1):471-5. PubMed ID: 7525530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.